Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Rheumatology

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 8782129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

  1993cited by this paper
• Corticosteroid-induced osteoporosis.

  1993cited by this paper
• The interchangeability of radioisotope and X-ray based measurements of bone mineral density.

  1991cited by this paper
• Corticosteroids and bone

  1984cited by this paper
• Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

  1984cited by this paper
• Steroid-induced fractures and bone loss in patients with asthma.

  1983cited by this paper
• Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

  1982cited by this paper
• Isolated skeletal involvement in Cushing's syndrome: response to therapy.

  1981cited by this paper
• Drug-induced disorders of vitamin D and mineral metabolism.

  1980cited by this paper
• Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

  1979cited by this paper
• Minimization: A new method of assigning patients to treatment and control groups

  1974cited by this paper

• Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

  2025cites this paper
• Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review

  2025cites this paper
• Effect of Calcium and Vitamin D on Bone Health among Kidney Transplant Recipients in a Prospective Randomized Controlled Trial

  2024cites this paper
• Clinical practice guideline for the prevention, diagnosis, and treatment of glucocorticoid-induced osteoporosis. Colombian Association of Rheumatology, 2023

  2024cites this paper
• Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and Older

  2023cites this paper
• Extensive Expertise in Endocrinology: Advances in the Management of Glucocorticoid-Induced Osteoporosis.

  2023cites this paper
• Guía de práctica clínica para la prevención, el diagnóstico y el tratamiento de la osteoporosis inducida por glucocorticoides. Asociación Colombiana de Reumatología, 2023

  2023cites this paper
• Requirements and Metabolism for Calcium, Phosphorus and Vitamin D3 in the Growing–Furring Blue Foxes

  2022cites this paper
• Understanding and Managing Corticosteroid-Induced Osteoporosis

  2021influential citation
• Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Management der Glukokortikoid-induzierten Osteoporose

  2021cites this paper
• Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis

  2021cites this paper
• German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis

  2021cites this paper
• An Overview of Glucocorticoid Induced Osteoporosis-Endotext-NCBI Bookshelf

  2019cites this paper
• Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice

  2019cites this paper
• Metabolic Bone Disease in Gastrointestinal Disorders

  2019cites this paper
• Glucocorticoid induced osteoporosis

  2019cites this paper
• Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses

  2018cites this paper
• Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis

  2018cites this paper
• Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update

  2018cites this paper
• Glucocorticoid-induced osteoporosis: an update

  2018cites this paper
• Importancia de los niveles de vitamina d en la prevención secundaria de la osteoporosis corticoidea

  2017cites this paper
• Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.

  2017cites this paper
• Micronutrients Deficiencies in Rheumatoid Arthritis Patients

  2016cites this paper
• Calcium intake, calcium homeostasis and health

  2016cites this paper
• Prevention and Treatment of Bone Disease in Systemic Lupus Erythematosus

  2016cites this paper
• Vitamin D as an adjunctive therapy in asthma. Part 1: A review of potential mechanisms.

  2015cites this paper
• Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk

  2015cites this paper
• Management of endocrine disease: Secondary osteoporosis: pathophysiology and management.

  2015cites this paper
• Drug Information Rounds

  2015cites this paper
• Glucocorticoid-induced osteoporosis

  2015cites this paper
• Secondary osteoporosis : pathophysiology and management

  2015cites this paper
• Vitamin D supplementation for prevention of mortality in adults.

  2014cites this paper
• Icariin Protects Against Glucocorticoid-Induced Osteoporosis In Vitro and Prevents Glucocorticoid-Induced Osteocyte Apoptosis In Vivo

  2013cites this paper
• The role of vitamin D supplementation in patients with rheumatic diseases

  2013cites this paper
• Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids

  2013cites this paper
• Bone mineral density in patients with atopic dermatitis.

  2012cites this paper
• Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone

  2012cites this paper
• Corticosteroid-Induced Osteoporosis

  2012influential citation
• [Steroid-induced osteoporosis].

  2012cites this paper
• Glucocorticoid-Induced Osteoporosis: Basic Pathological Mechanisms, Clinical Features, and Management in the New Millennium

  2011cites this paper
• Glucocorticoids and Vitamin D

  2011cites this paper
• Osteoporosis inducida por corticoides

  2011cites this paper
• The Pharmacology of Vitamin D

  2011cites this paper
• Corticosteroid and Nonsteroidal Anti-Inflammatory Drug use in Systemic Lupus Erythematosus

  2011cites this paper
• Vitamin D supplementation for prevention of mortality in adults.

  2011cites this paper
• The Role of Vitamin D in Osteoarthritis and Rheumatic Disease

  2011cites this paper
• Chapter 18, The Spectrum of Pediatric Osteoporosis

  2011cites this paper
• Role of teriparatide in treatment of glucocorticoid-induced osteoporosis

  2010cites this paper
• Steroid-induced osteoporosis

  2010cites this paper
• Clinical Aspects of the Use of Vitamin D and Its Metabolites in Osteoporosis

  2010cites this paper
• Glucocorticoid-Induced Osteoporosis: A Review

  2010cites this paper
• Metabolic Bone Disease in Gastrointestinal Disorders

  2010cites this paper
• Therapeutic challenges in atopic dermatitis

  2010cites this paper
• Vitamin D and Bone Health; Potential Mechanisms

  2010cites this paper
• NOFSA Guideline for the Diagnosis and Management of Osteoporosis

  2010cites this paper
• Correction of the bone tissue changes in the deficit of mechanical loading

  2010cites this paper
• Glucocorticoid induced osteoporosis

  2010cites this paper
• Chapter 8 – Principles in Management of Systemic Lupus Erythematosus

  2010cites this paper
• Glucocorticoid-induced osteoporosis

  2009cites this paper
• Glucocorticoid-induced osteoporosis: treatment update and review

  2009cites this paper
• GLUCOCORTICOID-INDUCED OSTEOPOROSIS: RISK FACTORS, PREVENTION, AND TREATMENT WITH RISEDRONATE

  2009cites this paper
• Medicament has basic calcium and vitamin d.

  2009cites this paper
• COPD and osteoporosis

  2009cites this paper
• Potential of alfacalcidol for reducing increased risk of falls and fractures

  2009cites this paper
• Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats.

  2009cites this paper
• Genistein aglycone reverses glucocorticoid‐induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate

  2009cites this paper
• Prevention and treatment of glucocorticoid‐induced osteoporosis in daily dermatologic practice

  2008cites this paper
• Glucocorticoid‐induced osteoporosis

  2008cites this paper
• TherapeuticsClinical Studies Including Force of the EULAR Standing Committee for systemic lupus erythematosus. Report of a Task EULAR recommendations for the management of

  2008cites this paper
• Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats.

  2008cites this paper
• [Not Available].

  2007cites this paper
• Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

  2007cites this paper
• Pathological Changes in Bone Metabolism : Implication for Bone Erosion and Osteoporosis

  2007cites this paper
• A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.

  2007cites this paper
• ModerneTherapie bei systemischem Lupus erythematodes

  2007cites this paper
• EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

  2007cites this paper
• Corticotrophins, Corticosteroids and Prostaglandins

  2007cites this paper
• Medication-induced osteoporosis

  2007cites this paper
• Osteoporosis inducida por glucocorticoides: ¿qué hay de nuevo?

  2007cites this paper
• [Relative value of plain vitamin D and of biologically active vitamin D in the prevention and treatment of osteoporosis].

  2006cites this paper
• A Double-Blind Placebo-Controlled Study of the Effects of the Bisphosphonate Risedronate on Bone Mass in Patients with Inflammatory Bowel Disease

  2006cites this paper
• Glucocorticoid-induced osteoporosis: mechanisms and therapeutic approach.

  2006cites this paper
• Stellenwert von nativem und biologisch aktivem Vitamin D bei der Prävention und Therapie der Osteoporose

  2006cites this paper
• Bone Mineral Density in Children with Relapsing Nephrotic Syndrome

  2006cites this paper
• Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures

  2006cites this paper
• Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia

  2006cites this paper
• Rehabilitation in Patients with Inflammatory Bowel Disease and Familial Adenomatous Polyposis

  2006cites this paper
• Osteoporosis in health and disease: a dermatologist's perspective.

  2006cites this paper
• Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation

  2006cites this paper
• Glucocorticoid-Induced Osteoporosis

  2006cites this paper
• Standards for performing DXA in individuals with secondary causes of osteoporosis.

  2006cites this paper
• Bone Mineral Density Assessment in Premenopausal Women

  2006cites this paper
• How to prevent steroid induced osteoporosis

  2005cites this paper
• Osteoporosis in systemic lupus erythematosus mechanisms.

  2005cites this paper
• Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.

  2005cites this paper
• Osteoporosis and Aging Females

  2005cites this paper
• The D-hormone analog alfacalcidol: the pioneer beyond the horizon of osteoporosis treatment.

  2005cites this paper
• Osteoporosis associated with excess glucocorticoids.

  2005cites this paper
• In whom and how to prevent glucocorticoid-induced osteoporosis.

  2005cites this paper
• Glucocorticoide: Stellenwert in der Therapie der Vaskulitis

  2005cites this paper